Citations

Mayo Clinic

Clear

12 citation(s) found for "Yang, Ronghua".

Camlipixant Reduces Burden of Cough-related Urinary Incontinence in Patients With Refractory Chronic Cough in Post-hoc Analysis of A Phase 2b Trial
Taliercio, Rachel M., Birring, Surinder S. , Lanouette, S., Yang, Ronghua , Garin, Margaret , Bonuccelli, Catherine M., Iyer, Vivek , Dicpinigaitis, Peter V. , Smith, John A. , Yang, R.

D25. EMERGING RESEARCH IN COUGH, CYSTIC FIBROSIS AND BRONCHIECTASIS | April 30, 2024 | Volume: No volume available | Issue: No issue available | Pages: A7083-A7083

10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a7083 Get It

Efficacy of Two Dose Regimens of Subcutaneous Fremanezumab Versus Placebo for the Preventive Treatment of Chronic Migraine (S32.005)
Silberstein, Stephen D., Aycardi, Ernesto, Bigal, Marcelo E. , Yeung, Paul, Blankenbiller, Tricia , Grozinski‐Wolff, Melissa, Yang, Ronghua , Ma, Yuju, Dodick, David W. , Goadsby, Peter J.

Neurology | December 7, 2023 | Volume: 90 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.90.15_supplement.s32.005 Get It

Efficacy Of Fremanezumab in Patients With Chronic Migraine With or Without Concomitant Use of Preventive Medication (P4.099)
Silberstein, Stephen D., Yeung, Paul, Blankenbiller, Tricia , Ning, Xiaoping , Yang, Ronghua , Ma, Yuju, Aycardi, Ernesto, Bigal, Marcelo E. , Goadsby, Peter J. , Dodick, David W.

Neurology | December 7, 2023 | Volume: 90 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.90.15_supplement.p4.099 Get It

Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab Versus Placebo for the Preventive Treatment of Episodic Migraine (P4.093)
Aycardi, Ernesto, Bigal, Marcelo E. , Yeung, Paul, Blankenbiller, Tricia , Grozinski‐Wolff, Melissa, Yang, Ronghua , Ma, Yuju, Silberstein, Stephen D., Dodick, David W. , Goadsby, Peter J.

Neurology | December 7, 2023 | Volume: 90 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.90.15_supplement.p4.093 Get It

Long-Term Efficacy of Fremanezumab in Patients Who Reverted From a Chronic to an Episodic Migraine Classification (S17.006)
Cohen, Joshua M. , Yeung, Paul, Yang, Ronghua , Seminerio, Michael J., Campos, Verena Ramirez, Lipton, Richard B. , Singh, Rashmi B. Halker , Ailani, Jessica

Neurology | December 7, 2023 | Volume: 92 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.92.15_supplement.s17.006 Get It

Impact of Fremanezumab on Response Rates, Acute Medication Use, and Disability in Patients With Episodic Migraine Who Have Failed at Least One Prior Migraine Preventive Medication (P2.10-001)
Winner, Paul, Cohen, Joshua M. , Yang, Ronghua , Yeung, Paul, Campos, Verena Ramirez, Singh, Rashmi B. Halker

Neurology | December 7, 2023 | Volume: 92 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.92.15_supplement.p2.10-001 Get It

Improvement in Response Over Time With Fremanezumab in Patients Who Reverted From a Chronic to an Episodic Migraine Classification (P1.10-013)
Cohen, Joshua M. , Yeung, Paul, Yang, Ronghua , Singh, Rashmi B. Halker , Marmura, Michael J.

Neurology | December 7, 2023 | Volume: 92 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.92.15_supplement.p1.10-013 Get It

Efficacy of Fremanezumab in Migraine Patients Who Have Failed at Least One Prior Migraine Preventive Medication (P1.10-011)
McAllister, Peter , Cohen, Joshua M. , Yang, Ronghua , Yeung, Paul, Campos, Verena Ramirez, Dodick, David W.

Neurology | December 7, 2023 | Volume: 92 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.92.15_supplement.p1.10-011 Get It

Impact of Fremanezumab on Headache-related Disability in Patients With Migraine and Documented Inadequate Response to 2–4 Classes of Migraine Preventive Medication Classes in the Open–label Extension of the Phase 3b FOCUS Study (4416)
Starling, Amaal J. , Ramirez-Campos, Verena, Ning, Xiaoping , Cohen, Joshua M. , Yang, Ronghua

Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.94.15_supplement.4416 Get It

Long-term safety, tolerability, and efficacy of fremanezumab in migraine
Goadsby, Peter J. , Silberstein, Stephen D., Yeung, Paul, Cohen, Joshua M. , Ning, Xiaoping , Yang, Ronghua , Dodick, David W. , Yeung, Paul P, Goadsby, Peter J , Dodick, David W

Neurology | September 11, 2020 | Volume: 95 | Issue: 18 | Pages: No page available

10.1212/wnl.0000000000010600 | PMID 32913018 Get It